Integra LifeSciences

Forecast & Rating13 analysts currently cover Integra LifeSciences, with about 23.1% giving a positive rating — meaning they expect the stock to rise. The average price target is $19.56, about 13.4% upside from the current price of $17.24. Price targets range from $14.00 to $27.00 — a wide spread, showing clear disagreement over just how much Integra LifeSciences can rise. Historically, about 30.1% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Integra LifeSciences's outlook. Data as of Aug 4, 2026; for reference only and not investment advice.